Skip to main content
. 2022 Feb 26;36:14. doi: 10.47176/mjiri.36.14

Table 2. Demographic Information of the Individuals who participated in the Evaluation Process of the Tumorfight Application .

Variable Frequency Percent
Gender Men 14
13
51.9
48.1
Women
Age 31-40 7
8
12
25.9
29.6
44.4
41-50
More than 50
Marital status Married 19
8
92.6
7.4
Single
Type of treatment Esophagus 9
5
13
33.3
18.5
48.1
Abdomen
Intestine
Education level Post-secondary 4
23
14.8
85.2
Other
Chemotherapy duration Less than 6 months 4
12
11
14.8
44.4
40.7
6-12 months
12-24 months